Inside J&J’s Approach to New Company Creation

The healthcare giant’s approach to new venture creation, in partnership with outside venture capital firms, got rolling in 2021. We talk with Sanjay Mistry, VP of Venture Investments and New Company Creation…

By Evan Schwartz and Hadley Thompson · February 23, 2024 · 1 min read

Last summer, amidst a tough environment for biotech startups trying to raise money, a Cambridge biotech called Rapport Therapeutics announced a fresh infusion of $150 million. That brought its total funding to $250 million — all raised in 2023. Rapport’s key asset — a way to…